Risynth Bio
Semaglutide
Finnrick tested 4 samples of Semaglutide (GLP-1 agonist) from Risynth Bio between 1 Sep 2025 and 2 Mar 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Risynth Bio
Semaglutide
Tested 4 Samples
Last test 2 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Semaglutide tests from top-rated vendors:
All Semaglutide tests from Risynth Bio
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
2 Mar 2026
First
1 Sep 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 2 Mar 2026 | View | 20mg | 21.1mg | +5.5% | 99.90% | 2025/6-6-15-SEMAG | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 4 Sep 2025 | View | 10mg | 9.83mg | -1.7% | 99.95% | 2025/6-7-15SG | Gray Label / Silver Crimp / White Cap | Lab E | Public | |
| 1 Sep 2025 | View | 5mg | 5.19mg | +3.8% | 99.13% | 2025/6-7-15-SG | White Label / Silver Crimp / Blue Cap | Lab A | Public | |
| 1 Sep 2025 | View | 20mg | 19.88mg | -0.6% | 99.65% | 2025/6-7-15-SG | Gray Label / Silver Crimp / Purple Cap | Lab A | Public | |